文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

间充质干细胞通过旁分泌方式诱导功能活跃的 T 调节性淋巴细胞,并改善实验性自身免疫性葡萄膜炎。

Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis.

机构信息

Department of Oncology, Biology, and Genetics, University of Genoa, Genoa, Italy.

出版信息

Invest Ophthalmol Vis Sci. 2012 Feb 16;53(2):786-93. doi: 10.1167/iovs.11-8211. Print 2012 Feb.


DOI:10.1167/iovs.11-8211
PMID:22232435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3317420/
Abstract

PURPOSE: Mesenchymal stem/progenitor cells (MSCs) have regenerative and immunomodulatory properties, exerted by cell-cell contact and in a paracrine fashion. Part of their immunosuppressive activity has been ascribed to their ability to promote the induction of CD4+CD25+FoxP3+ T lymphocytes with regulatory functions (Treg). Here the authors studied the effect of MSCs on the induction of Treg and on the development of autoimmunity, and they examined the possibility that MSC-mediated Treg induction could be attributed to the secretion of soluble factors. METHODS: The authors induced experimental autoimmune uveitis (EAU) in mice by immunization with the 1-20 peptide of the intraphotoreceptor binding protein. At the same time, some of the animals were treated intraperitoneally with syngeneic MSCs. The authors checked T-cell responses and in vitro Treg conversion by cell proliferation and blocking assays, in cell-cell contact and transwell settings. TGFβ and TGFβ receptor gene expression analyses were performed by real-time PCR. RESULTS: The authors found that a single intraperitoneal injection of MSCs was able to significantly attenuate EAU and that a significantly higher percentage of adaptive Treg was present in MSC-treated mice than in MSC-untreated animals. In vitro blocking of antigen presentation by major histocompatibility complex class II precluded priming and clonal expansion of antigen-specific Treg, whereas blockade of TGFβ impaired the expression of FoxP3, preventing the conversion of CD4+ T cells into functionally active Treg. CONCLUSIONS: The authors demonstrated that MSCs can inhibit EAU and that their immunomodulatory function is due at least in part to the induction of antigen-specific Treg in a paracrine fashion by secreting TGFβ.

摘要

目的:间充质干细胞(MSCs)具有再生和免疫调节特性,通过细胞-细胞接触和旁分泌方式发挥作用。它们部分免疫抑制活性归因于其诱导具有调节功能的 CD4+CD25+FoxP3+T 淋巴细胞(Treg)的能力。本文作者研究了 MSCs 对 Treg 诱导和自身免疫发展的影响,并探讨了 MSC 介导的 Treg 诱导是否归因于可溶性因子的分泌。

方法:作者通过用感光细胞内结合蛋白的 1-20 肽免疫诱导实验性自身免疫性葡萄膜炎(EAU)。同时,一些动物通过腹腔内给予同基因 MSCs 进行治疗。作者通过细胞增殖和阻断试验、细胞-细胞接触和 Transwell 实验检查 T 细胞反应和体外 Treg 转化。通过实时 PCR 进行 TGFβ 和 TGFβ 受体基因表达分析。

结果:作者发现单次腹腔内注射 MSCs 可显著减轻 EAU,并且在 MSC 处理的小鼠中适应性 Treg 的比例明显高于未处理的 MSC 动物。主要组织相容性复合物 II 类抗原呈递的体外阻断排除了抗原特异性 Treg 的启动和克隆扩增,而 TGFβ 的阻断则损害了 FoxP3 的表达,阻止了 CD4+T 细胞向功能活跃的 Treg 的转化。

结论:作者证明了 MSCs 可以抑制 EAU,并且它们的免疫调节功能至少部分归因于通过分泌 TGFβ 以旁分泌方式诱导抗原特异性 Treg。

相似文献

[1]
Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis.

Invest Ophthalmol Vis Sci. 2012-2-16

[2]
Induction of antigen-specific Treg cells in treating autoimmune uveitis via bystander suppressive pathways without compromising anti-tumor immunity.

EBioMedicine. 2021-8

[3]
Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity.

Invest Ophthalmol Vis Sci. 2011-5-16

[4]
Enhanced immunosuppressive capability of mesenchymal stem cell-derived small extracellular vesicles with high expression of CD73 in experimental autoimmune uveitis.

Stem Cell Res Ther. 2024-5-23

[5]
Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.

Invest Ophthalmol Vis Sci. 2009-8-20

[6]
Treatment With FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitis.

Front Immunol. 2020-9-4

[7]
Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.

Cell Transplant. 2014-4

[8]
Inhibition of Noninfectious Uveitis Using Intravenous Administration of Collagen II-Specific Type 1 Regulatory T Cells.

Invest Ophthalmol Vis Sci. 2015-10

[9]
Biopotency and surrogate assays to validate the immunomodulatory potency of extracellular vesicles derived from mesenchymal stem/stromal cells for the treatment of experimental autoimmune uveitis.

J Extracell Vesicles. 2024-8

[10]
Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.

Invest Ophthalmol Vis Sci. 2011-5-17

引用本文的文献

[1]
Potential therapeutic applications of stem cells in animal models of ocular affections.

Inflamm Regen. 2025-7-21

[2]
New insights into the phenomenon of remissions and relapses in autoimmune diseases and the puzzle of benign autoantibodies in healthy individuals.

Front Immunol. 2025-5-9

[3]
Regulatory T Cells: Therapeutic Opportunities in Uveitis.

Front Ophthalmol (Lausanne). 2022-5-25

[4]
Exosomes in asthma: Underappreciated contributors to the pathogenesis and novel therapeutic tools.

Immun Inflamm Dis. 2024-6

[5]
Enhanced immunosuppressive capability of mesenchymal stem cell-derived small extracellular vesicles with high expression of CD73 in experimental autoimmune uveitis.

Stem Cell Res Ther. 2024-5-23

[6]
Mesenchymal stem cell based therapies for uveitis: a systematic review of preclinical studies.

Eye (Lond). 2024-7

[7]
Cell-based therapy in prophylaxis and treatment of chronic graft-versus-host disease.

Front Immunol. 2022

[8]
Effect of small extracellular vesicles derived from IL-10-overexpressing mesenchymal stem cells on experimental autoimmune uveitis.

Stem Cell Res Ther. 2022-3-7

[9]
Mesenchymal Stem Cell Induced Foxp3(+) Tregs Suppress Effector T Cells and Protect against Retinal Ischemic Injury.

Cells. 2021-11-4

[10]
Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases.

Front Immunol. 2021

本文引用的文献

[1]
Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions.

Tissue Eng Part C Methods. 2011-9-6

[2]
The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population.

Stem Cells Dev. 2011-7-26

[3]
Role of mesenchymal stem cells in reestablishing immunologic tolerance in autoimmune rheumatic diseases.

Arthritis Rheum. 2011-9

[4]
Transforming growth factor β-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis.

Arthritis Rheum. 2011-6

[5]
Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity.

Invest Ophthalmol Vis Sci. 2011-5-16

[6]
Regulatory influence of scaffolds on cell behavior: how cells decode biomaterials.

Curr Pharm Biotechnol. 2011-2-1

[7]
Stability of the regulatory T cell lineage in vivo.

Science. 2010-9-24

[8]
Induction of regulatory T cells by infliximab in Behcet's disease.

Invest Ophthalmol Vis Sci. 2011-1-21

[9]
A look at autoimmunity and inflammation in the eye.

J Clin Invest. 2010-9-1

[10]
FOXP3+ regulatory T cells in the human immune system.

Nat Rev Immunol. 2010-6-18

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索